Inhibition of methotrexate resistant mutant of Streptococcus faecalis by analogs of purine and pyrimidine.
D000225:Adenine / Q000494:pharmacology; D000227:Adenine Nucleotides / Q000494:pharmacology; D001375:Azaguanine / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D013293:Enterococcus faecalis / Q000187:drug effects*; D006147:Guanine / Q000494:pharmacology; D007700:Kinetics; D015122:Mercaptopurine / Q000494:pharmacology; D008727:Methotrexate / Q000037:antagonists & inhibitors; D009154:Mutation; D009705:Nucleosides / Q000494:pharmacology; D011687:Purines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology; D013866:Thioguanine / Q000494:pharmacology; D013941:Thymine / Q000378:metabolism*
D000227:Adenine Nucleotides; D009705:Nucleosides; D011687:Purines; D011743:Pyrimidines; D006147:Guanine; D015122:Mercaptopurine; D013866:Thioguanine; D000225:Adenine; D001375:Azaguanine; D013941:Thymine; D008727:Methotrexate